Globe Life (NYSE:GL) Issues FY 2026 Earnings Guidance

Globe Life (NYSE:GL) issued an update on its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 15.550-15.950 for the period, compared to the consensus EPS estimate of 15.650. The company issued revenue guidance of -.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. TD Cowen upped their price target on shares of Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday. Keefe, Bruyette & Woods raised their price objective on shares of Globe Life from $180.00 to $192.00 and gave the stock an “outperform” rating in a research note on Monday, July 13th. Morgan Stanley upped their target price on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. JPMorgan Chase & Co. increased their price target on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a report on Tuesday. Finally, Wells Fargo & Company raised their price target on Globe Life from $172.00 to $193.00 and gave the stock an “overweight” rating in a research note on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $187.60.

Globe Life Stock Down 0.3%

Globe Life stock traded down $0.63 during mid-day trading on Wednesday, reaching $183.71. 899,519 shares of the company were exchanged, compared to its average volume of 550,475. The business has a fifty day moving average of $167.76 and a 200 day moving average of $152.23. Globe Life has a 12-month low of $122.48 and a 12-month high of $191.55. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. The firm has a market cap of $14.26 billion, a P/E ratio of 12.70 and a beta of 0.47.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). The business had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Research analysts anticipate that Globe Life will post 15.64 earnings per share for the current fiscal year.

Globe Life Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be given a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio is presently 9.13%.

Insider Buying and Selling

In other Globe Life news, CEO Frank M. Svoboda sold 20,000 shares of Globe Life stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.68, for a total transaction of $3,133,600.00. Following the completion of the sale, the chief executive officer owned 54,020 shares of the company’s stock, valued at approximately $8,463,853.60. The trade was a 27.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Cheryl Alston sold 8,258 shares of the business’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the sale, the director owned 16,621 shares in the company, valued at approximately $2,979,148.04. The trade was a 33.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 124,187 shares of company stock worth $19,529,414 over the last three months. Corporate insiders own 2.11% of the company’s stock.

Key Stories Impacting Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life reported second-quarter net operating income of $3.61 per share, up from $3.27 a year ago, and revenue of $1.60 billion slightly beat estimates, showing continued business strength. GLOBE LIFE INC. REPORTS SECOND QUARTER 2026 RESULTS
• Positive Sentiment: Several analysts turned more bullish on the stock, including TD Cowen raising its price target to $225 and JPMorgan lifting its target to $201, signaling confidence in Globe Life’s earnings outlook. Benzinga analyst update
• Neutral Sentiment: The company updated FY 2026 EPS guidance to $15.55-$15.95, which is broadly in line with the consensus estimate of $15.65 and suggests no major change to the longer-term outlook.
• Negative Sentiment: Globe Life’s quarterly EPS of $3.61 missed analyst expectations of $3.67, which may be weighing on the stock despite the revenue beat. Press Release

Hedge Funds Weigh In On Globe Life

Institutional investors have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Globe Life by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after acquiring an additional 607 shares during the last quarter. NewEdge Advisors LLC lifted its position in Globe Life by 368.1% during the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after purchasing an additional 5,352 shares during the period. Goldman Sachs Group Inc. boosted its holdings in Globe Life by 11.5% in the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after purchasing an additional 58,163 shares during the last quarter. Empowered Funds LLC acquired a new stake in Globe Life during the 1st quarter worth about $428,000. Finally, Focus Partners Wealth raised its stake in shares of Globe Life by 8.3% during the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after buying an additional 656 shares during the last quarter. 81.61% of the stock is owned by hedge funds and other institutional investors.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.